Clinical Trials Logo

Active Immunization clinical trials

View clinical trials related to Active Immunization.

Filter by:
  • None
  • Page 1

NCT ID: NCT04799808 Recruiting - Immunosuppression Clinical Trials

Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and Staff

DIA-Vacc
Start date: January 15, 2021
Phase:
Study type: Observational

To investigate short- (3 and 8 weeks) and long-term (6, 9, 12, and 18 months) immune protection or response at the humoral and cellular levels before and after SARS-CoV-2 infection or vaccination in patients with moderately reduced immune status (dialysis patients) and severely reduced immune status (organ transplant recipients, mostly kidney transplant recipients) and immunocompetent subjects (medical staff) in Saxony, Germany.

NCT ID: NCT00655148 Completed - Active Immunization Clinical Trials

Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine

Start date: September 2003
Phase: Phase 3
Study type: Interventional

The trial is a parallel group, multi-centre, randomized, double blind, non-inferiority trial investigating the immunogenicity and safety of two DTaP-IPV combination vaccines: A)The investigational vaccine: DTaP-IPV containing IPV produced in a vero-cell line (DTaP-IPVvero) B)The reference vaccine: DTaP-IPV containing IPV produced in monkey kidney cells (DTaP-IPVmkc) The DTaP-IPV vaccines are administered to healthy infants at 2, 3½, 5, and 16 months of age concomitantly with Act-HIB vaccine administered as a separate injection in the opposite thigh. Three blood samples are collected at 6, 16 and 17 months of age. Sera are analyzed for antibodies against diphtheria, tetanus, pertussis, polio and prp.